Investors/Media

News Releases

January 6, 2021
-CAHmelia Adult Classic CAH Program Underway in U.S. and Europe - -Initiation of Phase 2 Pediatric Classic CAH Program Anticipated in Second Half of 2021- -Initiation of Phase 2 Polycystic Ovary Syndrome Program Anticipated in Second Half of 2021- -New Patent Issuance Extends Tildacerfont Patent